Table 5.
Risk Factor Models for Medication Nonadherence in White Participants with Heart Failure that were Significant in Bivariate Analyses
| Variable Type | Variable | Risk Factor | n (%)a | OR | p | 95% CI |
|---|---|---|---|---|---|---|
| Demographics | Age | ≥ 61 | 94 (63.1) | 3.18 | .009 | 1.34–7.52 |
| Social support | – | |||||
| Clinical | Comorbidities | ≥ 4 | 50 (33.6) | 2.15 | .044 | 1.02–4.51 |
| Months since heart failure diagnosis | ≥ 153 (vs. < 153 or missing) | 19 (12.8) | 2.76 | .044 | 1.03–7.38 | |
| Total doses (medication) | ≥ 11 (vs. < 11 or missing) | 83 (55.7) | 2.42 | .025 | 1.12–5.23 | |
| Self-care | – | |||||
| Symptoms | – | |||||
| Cognition | TMTB score | ≥ 93 | 66 (44.3) | 2.22 | .033 | 1.07–4.61 |
Note. CI = confidence interval; OR = odds ratio; TMTB = Trail Making Test – B.
a
Out of 149 White participants with Medication Event Monitoring System data.